- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Tremfya rescues J&J's immunology sales to fuel strong Q3 | ||
| Di | China's NMPA clears Foresee's Camcevi 42 mg for prostate cancer | ||
| Di | Southern Research secures NIH funding for drug testing hub | ||
| Mo | FDA approves Teva's monthly injection of olanzapine for schizophrenia | ||
| Mo | FDA approves Asahi Kasei's Hovilpri for refractory HSV | ||
| Mo | Perceptive, Nucleus partner to support radiopharmaceutical development | ||
| Fr | Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO | ||
| Fr | Roche's Tecentriq snags FDA label expansion in type of colon cancer | ||
| Fr | Bio-Techne opens GMP small molecule facility in Bristol, UK | ||
| Fr | Biohaven partners with Ono in $100m IgG degrader deal | ||
| Do | Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout | ||
| Do | Change lifestyle before giving children weight loss medication, WHO says | ||
| Do | FDA approves Pfizer's Tukysa regimen for metastatic breast cancer | ||
| Do | 10x Genomics and Fred Hutch partner on cancer technologies | ||
| 07.10. | CAR-T specialist Caribou culls pipeline and seeks exit deal | ||
| 07.10. | KymaThera pulls in $80m to bring breast cancer drug to clinic | ||
| 07.10. | Rocket receives $150m credit facility to advance cardiovascular portfolio | ||
| 07.10. | Gilead Sciences signs five-year DevOps agreement with Cognizant | ||
| 06.10. | Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout | ||
| 06.10. | Lilly deepens ties with Gate Bioscience in $870m deal expansion | ||
| 06.10. | Alector shares up after sealing $1.27bn Roche Parkinson's disease license deal | ||
| 06.10. | CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug | ||
| 06.10. | Pacira partners with Molteni for Exparel commercialisation | ||
| 06.10. | AstraZeneca opens new R&D centre in Cambridge, US | ||
| 05.10. | Scientists claim Nobel Prize for approach behind light-activated gene therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.